Pfizer to Sponsor Large New Celebrex Trial  NEW YORK (Reuters) - Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck   Co.'s Vioxx, a drug in the same  class.